Physician profile
Rena M Johnson
NPI 1447267661
$6,834.33
in general payments reported to CMS, 2019-2025
53 companies · $1,186 in 2025
The $1,186 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,073 · 2021: $505 · 2022: $1,466 · 2023: $1,267 · 2024: $1,337 · 2025: $1,186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,789.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $923.35 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $821.43 | 2020-2025 | |
| Lilly USA, LLC | $518.86 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $471.54 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $467.80 | 2020-2024 | Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $383.91 | 2020-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Abbott Laboratories | $312.23 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $280.21 | 2020-2025 | Repatha, Otezla, Evenity |
| Exact Sciences Corporation | $233.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.08 | 2020-2024 | Jardiance |
| Eisai INC. | $181.80 | 2020-2022 | |
| Amarin Pharma, INC. | $170.93 | 2020-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $170.60 | 2022 | |
| Glaxosmithkline, LLC. | $115.58 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $110.00 | 2025 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rena Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.